http://www.xconomy.com/boston/2007/06/07/shareholder-uprising-aims-to-disrupt-genzyme-takeover-deal-is-the-deal-too-true-to-be-good/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 12:29:49 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/boston/2007/06/07/shareholder-uprising-aims-to-disrupt-genzyme-takeover-deal-is-the-deal-too-true-to-be-good/comment-page-1/#comment-21 devo348 Fri, 08 Jun 2007 19:07:03 +0000 http://dev.xconomy.com/wordpress/2007/06/07/shareholder-uprising-aims-to-disrupt-genzyme-takeover-deal-is-the-deal-too-true-to-be-good/#comment-21 While the shareholders listed at the time you checked only accounted for 2% of shares, there are many other small holders and, more importantly, a large shareholder opposed to this deal. SCO Capital Partners LLC is publicly opposed and they hold 13.4% of the outstanding shares. In addition, Bioenvision is not naming who bought the recently issued 8 million shares. Something stinks here! While the shareholders listed at the time you checked only accounted for 2% of shares, there are many other small holders and, more importantly, a large shareholder opposed to this deal. SCO Capital Partners LLC is publicly opposed and they hold 13.4% of the outstanding shares. In addition, Bioenvision is not naming who bought the recently issued 8 million shares. Something stinks here!

]]>